Recombinant Human ITPR3 Protein，His

ITPR3, or Inositol 1,4,5-trisphosphate receptor type 3, is a critical protein involved in intracellular calcium signaling, playing a pivotal role in various physiological processes, including muscle contraction, neurotransmitter release, and cellular apoptosis. Its dysfunction has been implicated in several diseases, such as neurodegenerative disorders, cancer, and cardiovascular diseases, making it a significant target for therapeutic intervention. Research into the recombinant expression and purification of ITPR3 has gained momentum in recent years, driven by the need to understand its structure and function more effectively. By generating recombinant ITPR3 proteins, scientists can investigate the receptor's binding mechanisms, activation pathways, and regulatory interactions with other cellular components. Additionally, elucidating the structural details of ITPR3 can provide insights into its role in pathophysiology and aid in the design of specific inhibitors or modulators. The ability to produce high-quality, functional ITPR3 protein in heterologous systems has been essential for advancing our understanding of its biochemistry and its implications in human health and disease. Overall, the recombinant study of ITPR3 not only holds promise for basic research but also paves the way for potential clinical applications in targeting diseases associated with calcium signaling dysregulation.